These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma. Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093 [TBL] [Abstract][Full Text] [Related]
3. Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review. Murakami S; Nagano T; Nakata K; Onishi A; Umezawa K; Katsurada N; Yamamoto M; Tachihara M; Kobayashi K; Nishimura Y Intern Med; 2019 Oct; 58(19):2839-2843. PubMed ID: 31243239 [TBL] [Abstract][Full Text] [Related]
4. [A squamous cell lung cancer patient who developed immune hemolytic anemia after gemcitabine and docetaxel administration]. Agatsuma T; Koizumi T; Yasuo M; Urushihata K; Yamamoto H; Hanaoka M; Fujimoto K; Kubo K Gan To Kagaku Ryoho; 2009 Jul; 36(7):1145-7. PubMed ID: 19620805 [TBL] [Abstract][Full Text] [Related]
5. Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report. Ogawa K; Ito J; Fujimoto D; Morita M; Yoshizumi Y; Ariyoshi K; Tomii K; Katakami N Invest New Drugs; 2018 Jun; 36(3):509-512. PubMed ID: 29340837 [TBL] [Abstract][Full Text] [Related]
6. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors. Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978 [TBL] [Abstract][Full Text] [Related]
7. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus. So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558 [TBL] [Abstract][Full Text] [Related]
8. [A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer]. Yonenobu Y; Ishijima M; Toyooka K; Fujimura H Rinsho Shinkeigaku; 2019 Feb; 59(2):105-108. PubMed ID: 30700688 [TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab. Taki T; Oda N; Fujioka Y; Mitani R; Tokura T; Takata I; Oshiro Y; Takigawa N Intern Med; 2020 Jul; 59(13):1639-1642. PubMed ID: 32269191 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune hemolytic anemia: An unusual presentation of hemophagocytic lymphohistiocytosis in a pediatric post-liver transplant patient. Jarchin L; Chu J; Januska M; Merola P; Arnon R Pediatr Transplant; 2018 Nov; 22(7):e13281. PubMed ID: 30129086 [TBL] [Abstract][Full Text] [Related]
11. Atezolizumab-Induced Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia. Khosla A; Sandhu RS; Singhal S; Koka JM Am J Ther; 2024 May-Jun 01; 31(3):e324-e328. PubMed ID: 37433054 [No Abstract] [Full Text] [Related]
12. Pregnancy-induced hemophagocytic lymphohistiocytosis combined with autoimmune hemolytic anemia. Teng CL; Hwang GY; Lee BJ; Wang RC; Chou MM J Chin Med Assoc; 2009 Mar; 72(3):156-9. PubMed ID: 19299225 [TBL] [Abstract][Full Text] [Related]
13. Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer. Dang TO; Ogunniyi A; Barbee MS; Drilon A Expert Rev Anticancer Ther; 2016; 16(1):13-20. PubMed ID: 26588948 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of cold agglutinin disease associated with low-grade B-cell lymphoma in a patient receiving pembrolizumab for lung cancer. Karki NR; McElhone P; Savage N; Abdel Karim N BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400426 [TBL] [Abstract][Full Text] [Related]
15. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab. Radhi M; Rumelhart S; Tatman D; Goldman F J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011 [TBL] [Abstract][Full Text] [Related]
16. Coombs-negative Autoimmune Hemolytic Anemia Followed by Anti-erythropoetin Receptor Antibody-associated Pure Red Cell Aplasia: A Case Report and Review of Literature. Yoshimi M; Kadowaki Y; Kikuchi Y; Takahashi T Intern Med; 2016; 55(5):511-4. PubMed ID: 26935373 [TBL] [Abstract][Full Text] [Related]
17. Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab. Rassy EE; Assi T; Rizkallah J; Kattan J Immunotherapy; 2017 Mar; 9(4):309-311. PubMed ID: 28303768 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis. Wang C; Sun W; Li Z; Wu T; Fang W Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650 [TBL] [Abstract][Full Text] [Related]
19. Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the Al-Samkari H; Snyder GD; Nikiforow S; Tolaney SM; Freedman RA; Losman JA J Med Genet; 2019 Jan; 56(1):39-42. PubMed ID: 30287596 [TBL] [Abstract][Full Text] [Related]